Innovative ovarian cancer research newly supported by R37 MERIT Award
One of the most impactful advancements during the past decade in treating ovarian cancer is…
Browsing: Gynaecologic Cancers
Israel’s quality indicators show increase in breast and colorectal cancer screening, lag in cervical screenings
Researchers from Hebrew University-Hadassah in Jerusalem, Israel, and Cardioinfantil Foundation, Cardiology Institute in Bogota, Colombia,…
ESMO 2021: Maintenance Olaparib in Ovarian Cancer
Highlights on maintenance olaparib in ovarian cancer previously treated with PARPi
ESMO 2021: EORTC-1508 Study
Highlights on aspirin use in recurrent platinum-resistent ovarian cancer: EORTC-1508 study
ESMO 2021: FRAME Trial
Highlights on a phase I of dual RAF/MEK inhibitor + FAK inhibitor in ovarian cancer…
ESMO 2021: Immunotherapy prolongs survival in recurrent, persistent or metastatic cervical cancer
The addition of immunotherapy to standard first-line treatment extends survival by eight months for patients…
Cervical cancer rates stable or trending down in countries with effective screening measures
A recent trend analysis indicates that cervical cancer incidence and mortality rates have remained stable…
Lower-dose chemotherapy can be made more effective in killing HPV-induced cervical cancer cells
Researchers at Southern Methodist University, USA, have found a way to make chemotherapy drugs more…
Exploring the microscopic defects causing ovarian cancer to spread
Ovarian cancer devastates more than 20,000 women in the U.S. every year, due in part…
Ovarian cancer: Potential therapeutic target identified
A gene called DOT1L appears to play a role in progression and severity of ovarian…